U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT07599293) titled 'Emulation of the EMPEROR-Preserved Trial Using Healthcare Claims Data' on May 14.
Brief Summary: Investigators are building an empirical evidence base for real world data through large-scale emulation of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such studies.
Study Start Date: Oct. 13, 2024
Study Type: OBSERVATIONAL
Condition:
Heart Failure With Preserved Ejection Fraction
Chronic Heart Failure
Type 2 Diabetes Mellitus
Intervention:
DRUG: Empagliflozin
Initiation of empagliflozin desc...